Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elke Jordan
Observed name:
E Jordan
Institution:
Bavarian Nordic (Germany)
Observed institution:
Bavarian Nordic (Germany)
ORCID:
0000-0001-6821-795X
Observed ORCID:
0000-0001-6821-795X
OpenAlex ID:
A5006000355
Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine
2020
·
Elke Jordan
, Steven J Lawrence
, et al.
·
The Journal of Infectious Diseases
·
61
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial
2020
·
Nathaly Samy
, Daniela Reichhardt
, et al.
·
Vaccine
·
59
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine
2023
·
Elke Jordan
, Golam Kabir
, et al.
·
The Journal of Infectious Diseases
·
44
PDF
A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study
2024
·
Elke Jordan
, Victoria Jenkins
, et al.
·
Vaccine
·
17
PDF
Protocol for a phase 3, randomized, double-blind clinical trial evaluating the safety and immunogenicity of the MVA-BN® vaccine against mpox in children aged 4 to less than 24 months in the Democratic Republic of the Congo: Data to guide future paediatric vaccination strategies
2026
·
Solange Milolo Tshilumba
, Paulina Morales Ruiz
, et al.
·
Vaccine
·
1
P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN®-multiantigen vaccine: high responder rate and considerable breadth of immunological response
2009
·
T Overton
, D Schmidt
, et al.
·
Retrovirology
·
1
PDF
LB747. Immune Responses of the Recombinant MVA-BN-RSV Vaccine against Respiratory Syncytial Virus Infection in an RSV Human Challenge Trial (HCT) in Healthy Adult Participants
2022
·
Darja Schmidt
, Günter Silbernagl
, et al.
·
Open Forum Infectious Diseases
Show more works
View as search
Works count:
7
Citation count:
183
H-index:
4
I10-index:
4
Year
Topic
Type